Submitted by Anonymous (not verified) on Tue, 10/16/2018 - 14:03
Meet the new director of MedicaidPoliticoAdvocacy groups (outside of pharma) generally gave good reviews: AHIP, the pharmaceutical benefits manager group PCMA and the Campaign for Sustainable Rx Pricing applauded the move.